Pre-Open Stock Movers 08/10: (ZEV) (ARCT) (FSR) Higher; (MILE) (SDCX) (RETA) Lower (more...)
Pre-Open Stock Movers:
Lightning eMotors (NYSE: ZEV) 59% HIGHER; Lightning eMotors and Forest River, Inc., a Berkshire Hathaway company (NYSE: BRK.A), today announced they have entered into a strategic partnership agreement to deploy up to 7,500 zero-emission shuttle buses.
Arcturus Therapeutics (NASDAQ: ARCT) 36% HIGHER; ARCT-021, Arcturus’ single shot STARR™ mRNA COVID vaccine, to begin multinational placebo-controlled Phase 3 efficacy study funded and sponsored by a global entity; ARCT-154, Arcturus’ STARR™ mRNA vaccine candidate targeting COVID variants of concern, elicits robust neutralizing antibody titers against all variants tested in primates, including the Delta variant; ARCT-154 to begin staged Phase 3 study in Vietnam; potential for EUA in December.
Metromile, Inc. (NASDAQ: MILE) 19.8% LOWER; business impacted by COVID
Fisker (NYSE: FSR) 19% HIGHER; Morgan Stanley resumes coverage with an Overweight rating and a price target of $40.00. The analyst sets a new $90 bull case.
SmileDirectClub (NASDAQ: SDC) 18.7% LOWER; reported Q2 EPS of ($0.14), $0.04 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $174.2 million versus the consensus estimate of $198.45 million. SmileDirectClub sees FY2021 revenue of $750-800 million, versus the consensus of $833.7 million.
Reata Pharmaceuticals, Inc. (NASDAQ: RETA) 17% LOWER; FDA Raises Kidney Drug Issues
3D Systems (NYSE: DDD) 14.3% HIGHER; reported Q2 EPS of $0.12, $0.07 better than the analyst estimate of $0.05. Revenue for the quarter came in at $162.6 million versus the consensus estimate of $143.28 million. Consistent with prior guidance, on a non-GAAP basis the company expects 2021 gross profit margins to be between 40% and 44%.
Purple Innovation (NASDAQ: PRPL) 11.1% HIGHER; reported Q2 EPS of $0.05, $0.07 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $182.6 million versus the consensus estimate of $176.99 million. Issues solid back-half guidance.
Casper Sleep Inc. (NYSE: CSPR) 7% LOWER; reported Q2 EPS of ($0.81), $0.47 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $151.8 million versus the consensus estimate of $151.28 million. Casper Sleep Inc. sees Q3 2021 revenue of $152-159 million, versus the consensus of $156 million.Casper Sleep Inc. sees FY2021 revenue of $580-610 million, versus the consensus of $609.4 million.
Compass (NYSE: COMP) 7% HIGHER; reported Q2 EPS of ($0.02), $0.11 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $1.95 billion versus the consensus estimate of $1.56 billion. Compass sees FY2021 revenue of $6.15-6.35 billion, versus the consensus of $5.5 billion.
Fluent, Inc. (NASDAQ: FLNT) 7% HIGHER; Q2 2021 revenue of $73.4 million, up 3% over Q2 2020
Halozyme Therapeutics (NASDAQ: HALO) 6.9% HIGHER; reported Q2 EPS of $0.66, $0.26 better than the analyst estimate of $0.40. Revenue for the quarter came in at $136.5 million versus the consensus estimate of $103.16 million. Halozyme Therapeutics sees FY2021 EPS of $1.85-$2.00, versus the consensus of $1.41. Halozyme Therapeutics sees FY2021 revenue of $425-445 million, versus the consensus of $404.6 million.
Kansas City Southern (NYSE: KSU) 6.5% HIGHER; Canadian Pacific Railway (NYSE: CP) is planning to make a new, increased offer for Kansas City Southern (NYSE: KSU), reigniting a takeover battle with Canadian National Railway (NYSE: CNI), according to Dow Jones, citing people familiar with the matter. CP's board met on Monday and authorized a bid that values KSU at $300 per share, or about $27 billion.
AMC Entertainment (NYSE: AMC) 5.7% HIGHER; reported Q2 EPS of ($0.71), $0.22 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $444.7 million versus the consensus estimate of $375.28 million.
Array Technologies (NASDAQ: ARRY) 5% HIGHER; Roth Capital upgraded from Neutral to Buy with a price target of $25.00.
Planet Fitness (NYSE: PLNT) 4.4% HIGHER; reported Q2 EPS of $0.21, $0.02 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $137.3 million versus the consensus estimate of $127.2 million. Planet Fitness sees FY2021 EPS of $0.65-$0.70, versus the consensus of $0.94. Planet Fitness sees FY2021 revenue of $530-540 million, versus the consensus of $541 million.